ENFORCEMENT DECREE OF THE BIOTECHNOLOGY SUPPORT ACT
Presidential Decree No. 14731, Jul. 13, 1995
Amended by Presidential Decree No. 16326, May 24, 1999
Presidential Decree No. 17048, Dec. 29, 2000
Presidential Decree No. 17115, Jan. 29, 2001
Presidential Decree No. 18452, jun. 29, 2004
Presidential Decree No. 20740, Feb. 29, 2008
Presidential Decree No. 22075, Mar. 15, 2010
Presidential Decree No. 24423, Mar. 23, 2013
Presidential Decree No. 25751, Nov. 19, 2014
Presidential Decree No. 28210, Jul. 26, 2017
Presidential Decree No. 31168, Nov. 20, 2020
Presidential Decree No. 31380, Jan. 5, 2021
Presidential Decree No. 32532, Mar. 15, 2022
CHAPTER I GENERAL PROVISIONS
The purpose of this Decree is to prescribe matters mandated by the Biotechnology Support Act and those necessary for the enforcement thereof. <Amended on Jul. 13, 1995; Nov. 20, 2020>
| Article 1-2 Deleted. <Mar. 15, 2022> |
CHAPTER II PLANNING AND IMPLEMENTATION SYSTEM FOR BIOTECHNOLOGY SUPPORT
| Article 2 (Establishment of Master Plans for Biotechnology Support) |
| (1) | The Minister of Science and ICT shall formulate a master plan for biotechnology support prescribed in Article 5 (2) of the Act (hereinafter referred to as "master plan") every five years and shall notify the heads of the relevant central administrative agencies of such plan. |
| (2) | Where necessary to formulate a master plan, the Minister of Science and ICT may request the heads of relevant central administrative agencies, the heads of relevant local governments, the heads of relevant educational or research institutions, or enterprises having participated in a national research and development project under Article 11 of the Framework Act on Science and Technology (hereinafter referred to as "national research and development project") to submit necessary materials. |
[This Article Wholly Amended on Nov. 20, 2020]
| Article 3 (Formulation of Annual Implementation Plans) |
| (1) | Each annual implementation plan under Article 6 (1) of the Act (hereinafter referred to as "implementation plan") shall include the following: |
| 1. | Outline of biotechnology-related projects (hereafter in this paragraph referred to as "projects"); |
| 2. | Business performance of the previous year and the business plan for the relevant year; |
| 3. | Detailed plan for each project; |
| 4. | Other matters that the Minister of Science and ICT deems necessary to be included in an implementation plan in order to facilitate the technological development and industrialization of biotechnology. |
| (2) | The head of a relevant central administrative agency shall formulate an implementation plan by January 31 of each year and shall submit such plan to the Council for Comprehensive Biotechnology Policy under Article 7 (1) of the Act (hereinafter referred to as the "Council"). |
| (3) | An implementation plan submitted pursuant to paragraph (2) shall be finalized after deliberation by the Council. |
| (4) | The Minister of Science and ICT shall notify the implementation plan finalized pursuant to paragraph (3) to the head of the relevant central administrative agency. |
[This Article Wholly Amended on Nov. 20, 2020]
| Article 4 (Preparation of Basic Guidelines Necessary for Formulating Implementation Plans) |
Where the Minister of Science and ICT prepares basic guidelines necessary for formulating implementation plans pursuant to Article 6 (3) of the Act, he or she shall refer such guidelines to the Council for deliberation. [This Article Wholly Amended on Nov. 20, 2020]
| Article 5 (Composition of Council) |
| (1) | Deleted. <Jun. 29, 2004> |
| (2) | “Vice-Ministerial level public officials of the relevant central administrative agencies who are prescribed by Presidential Decree" in Article 7 (4) 1 of the Act means the Vice Ministers of the following central administrative agencies; in such cases, where there are more than one Vice Minister in an agency, it shall be the one designated by the head of the relevant agency: <Amended on Jun. 29, 2004; Feb. 29, 2008; Mar. 15, 2010; Mar. 23, 2013; Nov. 19, 2014; Jul. 26, 2017; Nov. 20, 2020> |
| 1. | The Ministry of Economy and Finance; |
| 2. | The Ministry of Education; |
| 3. | The Ministry of Science and ICT; |
| 4. | The Ministry of Agriculture, Food and Rural Affairs; |
| 5. | The Ministry of Trade, Industry and Energy; |
| 6. | The Ministry of Health and Welfare; |
| 7. | The Ministry of Environment; |
| 8. | The Ministry of Oceans and Fisheries. |
| (3) | The members provided in Article 7 (4) 2 of the Act shall be commissioned by the Minister of Science and ICT in consideration of gender; and the terms of office for the commissioned members shall be two years. <Amended on Jun. 29, 2004; Feb. 29, 2008; Mar. 23, 2013; Jul. 26, 2017; Nov. 20, 2020> |
[Title Amended on Jun. 29, 2004]
| Article 6 (Duties of Chairperson of Council) |
| (1) | The chairperson of the Council shall exercise overall control and supervision of its affairs and shall convene and preside over its meetings. <Amended on Nov. 20, 2020; Jan. 5, 2021> |
| (2) | Where the chairperson of the Council is unable to perform his or her duties due to any unavoidable cause, a member designated by the chairperson shall act on behalf of the chairpersons. <Amended on Nov. 20, 2020> |
| (1) | The meetings of the Council shall be divided into regular and special meetings. |
| (2) | Regular meetings shall be convened once a year on a date designated by the Council, and special meetings shall be convened by the chairperson of the Council as the occasion arises. <Amended on Nov. 20, 2020> |
| (3) | The meetings shall come to order with a majority of all the registered members attending and resolutions shall be adopted by an affirmative vote of a majority of members present. |
| (1) | One secretary shall be appointed to the Council to handle general affairs of the Council. |
| (2) | The Minister of Science and ICT shall appoint one secretary from among public officials under his or her jurisdiction. <Amended on Jun. 29, 2004; Feb. 29, 2008; Mar. 23, 2013; Jul. 26, 2017> |
| Article 9 (Composition of Working Committee) |
| (1) | A working committee that may be established in the Council pursuant to Article 7 (5) of the Act (hereinafter referred to as the "working committee") shall be comprised of not more than 20 members, including one chairperson. |
| (2) | The First Vice Minister of Science and ICT shall serve as the chairperson of the working committee. |
| (3) | Members of the working committee shall be appointed or commissioned by the Minister of Science and ICT from among the following persons; in such cases, members falling under subparagraph 2 shall be commissioned in consideration of gender: |
| 1. | One public official designated by the head of each relevant agency from among public officials belonging to the Senior Executive Service of the relevant central administrative agency referred to in the subparagraphs of Article 5 (2); |
| 2. | Persons with extensive knowledge of and experience in fostering biotechnology and promoting the technological development and industrialization of biotechnology, who engage in academic circles, research institutes, medical institutions, or industrial circles. |
| (4) | The term of office of a member who is not a public official among the members commissioned pursuant to paragraph (3) shall be two years. |
[This Article Newly Inserted on Nov. 20, 2020]
| Article 9-2 (Operation of Working Committee) |
| 2. | Duties delegated by the Council; |
| 3. | Matters concerning fostering biotechnology and promoting industrialization thereof that require coordination of opinions between relevant central administrative agencies; |
| 4. | Other matters concerning fostering biotechnology and promoting industrialization thereof that the chairperson of the working committee deems necessary to be examined. |
| (2) | Where it is necessary to efficiently conduct an examination by the working committee, the working committee may have subcommittees for each field. |
| (3) | Matters necessary for the composition and operation of subcommittees under paragraph (2) shall be determined by the chairperson of the working committee after resolution by the working committee. |
| (4) | Except as provided in paragraphs (1) through (3), Articles 6 through 8 shall apply mutatis mutandis to the operation of the working committee. In such cases, the “Council” shall be deemed as the “working committee". |
[This Article Newly Inserted on Nov. 20, 2020]
| Article 10 (Hearing of Opinions) |
If deemed necessary, the Council or the working committee may have relevant public officials or experts with professional knowledge of and experience in biotechnology attend a meeting of the Council or the working committee to hear their opinions. <Amended on Jul. 13, 1995; Jun. 29, 2004; Nov. 20, 2020>
Allowances or actual expenses may be paid to members, related public officials, or related experts who attend a meeting of the Council or the working committee, within budgetary limits: Provided, That no payment shall be made to Council members who are public officials or related public officials, if they attend a meeting directly related to their duties. <Amended on Jun. 29, 2004; Nov. 20, 2020>
| Article 11-2 (Details and Scope of Detailed Policies to Support Biotechnology) |
When the head of a relevant central administrative agency formulates detailed policies for each field under his or her jurisdiction (hereinafter referred to as "detailed policies") pursuant to Article 8 (3) of the Act, he or she shall observe the details and scope as classified in the following: | 1. | Where the heads of the relevant central administrative agencies specified in the following formulate detailed policies, the details and scope of the following measures: |
| (a) | The Minister of Education: Policies to foster professional personnel and to support for basic research in the field of biotechnology, which are formulated in consultation with the Minister of Science and ICT; |
| (b) | The Minister of Science and ICT: Policies to formulate a master plan, to comprehensively coordinate policies for each agency, to assist the development of basic and original research and advanced technologies related to biotechnology, to support the research and development using information and communications technology, and to foster and develop biotechnology-related research institutes; |
| (c) | The Minister of Agriculture, Food and Rural Affairs: Policies to support applied research and industrialization thereof in the fields of agriculture, livestock, and food, such as the breeding of, and improvement of varieties of, animals, plants, and microorganisms and the development of food materials; |
| (d) | The Minister of Trade, Industry and Energy: Policies to support technological development and to promote industrialization thereof, such as the development and improvement of biotechnology-related manufacturing technologies and industrial processes and the development and utilization of new and renewable energy; |
| (e) | The Minister of Health and Welfare: Policies to conduct applied and clinical research and to support the development of advanced medical technology and industrialization thereof, in the field of biotechnology related to health and medical services; |
| (f) | The Minister of the Environment: Policies to support applied research and industrialization thereof in the field of environment, such as conservation of biodiversity, sustainable uses of its components, treatment of wastewater and wastes using biotechnology, and prevention of environmental pollution; |
| (g) | The Minister of Oceans and Fisheries: Policies to support applied research and industrialization thereof in the field of marine fisheries, such as the production of useful materials using marine fishery products, the breeding of, and improvement of varieties of, marine fishery products, the development of food materials, and the development of technology for preventing marine pollution; |
| 2. | Other details and scope determined in prior consultation with the Minister of Science and ICT, where the head of a relevant central administrative agency formulates detailed policies. |
[This Article Newly Inserted on Nov. 20, 2020]
| Article 11-3 (Procedures and Methods for Fact-Finding Surveys) |
| (1) | Where the head of a relevant central administrative agency intends to conduct a fact-finding survey pursuant to Article 9 (1) of the Act, he or she shall prepare a fact-finding survey plan including the objectives, subject matter, period, etc. of the survey and shall notify a person subject to the fact-finding survey in writing in advance. |
| (2) | A fact-finding survey under Article 9 (1) of the Act shall be conducted by means of on-site surveys, written surveys, statistical surveys, literature surveys, etc. and may be conducted using information and communications networks or electronic methods, such as e-mail, if necessary to efficiently conduct such survey. |
[This Article Newly Inserted on Nov. 20, 2020]
| Article 11-4 (Procedures for Technology Impact Assessment) |
| (1) | The specific technology (hereafter in this Article referred to as "technology subject to assessment") subject to technology impact assessment under Article 10 (1) of the Act (hereinafter referred to as "technology impact assessment") shall be determined by the Minister of Science and ICT in consultation with the heads of the relevant central administrative agencies, among new biotechnology with a great impact and ripple effect on economy, society, culture, ethics, environment, etc. |
| (2) | The Minister of Science and ICT may, if necessary for the technology impact assessment, request the heads of the relevant central administrative agencies and the heads of local governments to submit related materials. |
| (3) | The results of the technology impact assessment shall contain the following: |
| 1. | The impact of technology subject to assessment on the promotion of benefits of people's lives and the development of biotechnology-related industries; |
| 2. | The impact of the new biotechnology on the economy, society, culture, ethics, environment, etc.; |
| 3. | Other matters that the Minister of Science and ICT deems necessary to be included in the results of the technology impact assessment. |
| (4) | The technology impact assessment shall be finalized after deliberation by the Council. |
| (5) | The Minister of Science and ICT shall notify the heads of relevant central administrative agencies of the results of the technology impact assessment finalized pursuant to paragraph (4). |
[This Article Newly Inserted on Nov. 20, 2020]
CHAPTER III PROMOTION OF RESEARCH AND DEVELOPMENT OF BIOTECHNOLOGY
| Article 12 (Promotion of Joint or Convergence Research) |
Joint or convergence research under Article 12 (1) of the Act (hereinafter referred to as "joint or convergence research") means any of the following research: | 1. | Research that is conducted jointly by at least two institutions related to academic circles, research institutes, medical institutions, or industrial circles; |
| 2. | Research that creates new value through connection and cooperation made through an interdisciplinary approach or between technologies and industries. |
| (2) | In order to promote joint or convergence research pursuant to Article 12 (1) of the Act, the Government may conduct demand surveys to identify fields of projects requiring joint or convergence research. |
| (3) | The Minister of Science and ICT may give priority to implementing research and development projects related to the field of projects identified as a result of demand surveys under paragraph (2) and, if necessary, may request the head of a related central administrative agency to give priority to implementing research and development projects related to the identified field of projects. |
| (4) | In order to promote joint or convergent research among academic circles, research institutes, medical institutions, and industrial circles, the Minister of Science and ICT may recommend the joint purchase of research equipment and prototypes necessary for joint or convergence research, the joint use of research facilities, etc., and may provide necessary support. |
[This Article Wholly Amended on Nov. 20, 2020]
| Article 12-2 (Preparation of Experimental Guidelines) |
| (1) | The Minister of Health and Welfare shall prepare and implement experimental guidelines for the promotion of research and industrialization of biotechnology under Article 14 of the Act after deliberation by the Council. <Amended on Dec. 23, 1994; Jul. 13, 1995; Feb. 29, 2008; Mar. 15, 2010; Nov. 20, 2020> |
| (2) | The experimental guidelines referred to in paragraph (1) shall include the following matters: <Amended on Jul. 13, 1995> |
| 1. | Matters necessary to prevent biological risks such as the method of inhibiting the prevention of dissemination and increase of genetically modified organisms; |
| 2. | Matters necessary to prevent the occurrence of ethical problems such as the prohibition of genetic modification of human genes, etc. which may cause effects detrimental to the dignity of human beings. |
[Moved from Article 15 <Nov. 20, 2020>]
CHAPTER IV PROMOTION OF BIOTECHNOLOGY INDUSTRIALIZATION
| Article 13 (Support for Manufacture of New Technology Products) |
| (1) | The Minister of Science and ICT may request the head of a relevant central administrative agency to take necessary measures, such as providing funds and giving priority to purchasing products under his or her jurisdiction, after deliberation by the Council to support the promotion of manufacturing and selling new technology products related to biotechnology under subparagraph 7 of Article 15 of the Act. <Amended on Jul. 13, 1995; Jun. 29, 2004; Feb. 29, 2008; Mar. 23, 2013; Jul. 26, 2017; Nov. 20, 2020> |
| (2) | Upon receipt of a request under paragraph (1), the head of a relevant central administrative agency shall take necessary measures, such as providing funds and giving priority to purchasing products, unless there is a compelling reason not to do so. <Amended on Nov. 20, 2020> |
| Article 14 (Preparation of Guidelines for Clinical Testing and Inspection) |
| (1) | In order to establish a system of clinical testing and inspection for biotechnological products under Article 17 of the Act under their jurisdiction, the Minister of Agriculture, Food and Rural Affairs, the Minister of Trade, Industry and Energy, the Minister of Health and Welfare, the Minister of Environment, and the Minister of Oceans and Fisheries shall prepare and implement guidelines for clinical testing and inspection after deliberation by the Council: Provided, That this shall not apply where it is otherwise prescribed in other statutes or regulations. <Amended on Mar. 6, 1993; Dec. 23, 1994; Jul. 13, 1995; Jun. 29, 2004; Feb. 29, 2008; Mar. 15, 2010; Mar. 23, 2013; Nov. 20, 2020> |
| (2) | Guidelines for clinical testing and inspection under paragraph (1) shall include the following: Provided, That if there are matters which cannot be prescribed in such guidelines due to special characteristics of biotechnological products, such matters need not be prescribed in the guidelines: <Amended on Jul. 13, 1995; Nov. 20, 2020> |
| 1. | Animal tests of commodities produced or manufactured by using genetically modified organisms; |
| 2. | Clinical tests of pharmaceuticals produced or manufactured by using genetically modified organisms; |
| 3. | Analysis of components, degree of purity and degree of activity of commodities produced or manufactured by using genetically modified organisms; |
| 4. | Other necessary matters for clinical tests and inspection of biotechnological products. |
CHAPTER V LAYING FOUNDATIONS FOR BIOTECHNOLOGY
| Article 15 (Collection, Management, and Utilization of Biotechnology Information) |
| (1) | The Minister of Science and ICT may establish and operate an integrated management system for biotechnology-related information for the systematic management and utilization of biotechnology information under Article 19 (1) of the Act. |
| 1. | Information related to domestic and foreign technology, policies, industries, and systems in the field of biotechnology; |
| 2. | Information related to domestic and international academic journals, research papers, and patents in the field of biotechnology; |
| 3. | Information on tasks and research results related to national research and development projects in the field of biotechnology ; |
| 4. | Information on research and development personnel, facilities, and equipment in the field of biotechnology; |
| 5. | Information on technology transfer, commercialization, and technology start-up in the field of biotechnology; |
| 6. | Other information in the field of biotechnology for the revitalization of biotechnology research and development and for the promotion of industrialization thereof, which the Minister of Science and ICT deems necessary to collect, manage, and utilize. |
| (3) | The investigation of biotechnology-related information under Article 19 (2) of the Act shall be conducted every year: Provided, That it may be conducted occasionally where the Minister of Science and ICT deems it necessary. |
| (4) | Institutions that may request biotechnology-related information and materials related thereto pursuant to Article 19 (2) of the Act shall be as follows: |
| 1. | Relevant central administrative agencies and their affiliated research institutes; |
| 3. | National and public research institutes; |
| 7. | Other institutions determined by the Minister of Science and ICT, which are related to research on the technological development of biotechnology and the promotion of industrialization thereof. |
[This Article Newly Inserted on Nov. 20, 2020]
[Previous Article 15 moved to Article 12-2 <Nov. 20, 2020>]
| Article 15-2 (Establishment of Classification System) |
| (1) | Where the head of a relevant central administrative agency intends to establish a biotechnology classification system under Article 20 (1) of the Act (hereinafter referred to as "biotechnology classification system"), he or she shall consult with the Minister of Science and ICT in advance. |
| (2) | Where the head of a relevant central administrative agency intends to establish a biotechnology classification system pursuant to paragraph (1), such system may be established in a way that is linked to the National Standard Classification System for Science and Technology under Article 27 (1) of the Framework Act on Science and Technology. |
| (3) | The head of a relevant central administrative agency shall finalize the biotechnology classification system established pursuant to paragraph (1) after deliberation by the Council. |
| (4) | The head of a relevant central administrative agency may, if necessary, revise or supplement the biotechnology classification system in consideration of the innovation of biotechnology, the development trend of the biotechnology industry, etc. |
| (5) | Paragraphs (1) through (3) shall apply mutatis mutandis to the procedures for revision or supplementation under paragraph (4). In such cases, "establishment" shall be construed as "revision or supplementation". |
[This Article Newly Inserted on Nov. 20, 2020]
| Article 15-3 (Subject Matters and Methods of Survey and Analysis of Biotechnology Statistics) |
| (1) | The subject matters of survey and analysis of biotechnology statistics under Article 20 (1) of the Act shall be as follows: |
| 1. | Matters concerning the investment in and performance of research and development related to biotechnology, the technological level of biotechnology, and other similar information; |
| 2. | Matters concerning start-up information and investment or performance of enterprises, such as venture businesses related to biotechnology, the current status of the clusters of each hub, and other similar information; |
| 3. | Matters concerning biotechnology-related research facilities and equipment and other similar information; |
| 4. | Matters concerning human resources supplied by biotechnology-related universities, human resources employed by enterprises, and other similar information; |
| 5. | Other matters for which the Minister of Science and ICT deems it necessary to survey and analyze statistics in order to effectively formulate policies for the technological development and industrialization of biotechnology. |
| (2) | A survey of statistics under paragraph (1) shall be conducted by means of on-site surveys, questionnaires, literature surveys, etc. and may be conducted using information and communications networks or electronic methods, such as e-mail, if necessary to efficiently conduct such survey. |
[This Article Newly Inserted on Nov. 20, 2020]
| Article 15-4 (Improvement of Biotechnology-Related Regulation) |
| (1) | Where it is necessary to support the identification of regulation that needs improvement among regulation of the technological development and utilization of biotechnology and the examination of improvement measures under Article 22 (2) of the Act, the Minister of Science and ICT may organize and operate a joint team for regulatory improvement (hereinafter referred to as the "joint regulatory improvement team") comprised of any of the following persons: |
| 1. | An employee of a relevant central administrative agency who is appointed by the head of such agency; |
| 2. | An interested party of, or expert in, regulation of the technological development and utilization of biotechnology. |
| (2) | A joint regulatory improvement team shall identify unnecessary regulation that may impede the technological innovation of biotechnology and the creation of new industries and therefore needs improvement, through telephone surveys, face-to-face surveys, questionnaires, etc. and shall establish policies for improvement. |
| (3) | A joint regulatory improvement team shall give a report on identified regulation and established improvement policies under paragraph (2) to the Council. |
| (4) | The Council shall deliberate and decide on the regulation and improvement policies reported pursuant to paragraph (3). |
| (5) | The Minister of Science and ICT shall notify the head of a relevant central administrative agency of the regulation and improvement policies that are decided on by the Council pursuant to paragraph (4), and the head of the relevant central administrative agency shall endeavor to improve the relevant regulation in accordance with the notification unless there is a compelling reason not to do so. |
[This Article Newly Inserted on Nov. 20, 2020]
| Article 16 (Designation and Operation of Organization in Charge of Nurturing Basic Medical Science) |
| (1) | Any organization in charge of nurturing the basic medical science provided for in Article 25 (1) of the Act shall be designated by the Minister of Science and ICT and the Minister of Health and Welfare after they consult thereabout. <Amended on Feb. 29, 2008; Mar. 15, 2010; Mar. 23, 2013; Jul. 26, 2017; Nov. 20, 2020> |
| (2) | Each organization in charge of nurturing the basic medical science shall perform the following duties: <Amended on Nov. 20, 2020> |
| 1. | Undertaking and managing projects for nurturing the basic medical science; |
| 2. | Assistance in academic and research activities in the field of the basic medical science. |
[This Article Wholly Amended on Jun. 29, 2004]
| Article 17 Deleted. <Jun. 29, 2004> |
| Article 18 Deleted. <Jun. 29, 2004> |
| Article 19 Deleted. <Jun. 29, 2004> |
| Article 20 Deleted. <Jun. 29, 2004> |
| Article 21 Deleted. <Jun. 29, 2004> |
| Article 22 Deleted. <Jun. 29, 2004> |
| Article 23 (Shipment Prior to Acceptance of Import Declaration) |
| (1) | Items that may be allowed to be shipped prior to the acceptance of an import declaration thereon under Article 26 (2) of the Act shall be the following items which are determined by the Minister of Science and ICT: <Amended on Jul. 26, 2017; Nov. 20, 2020> |
| 2. | Radioactive substances reagents; |
| 3. | Microbial bacteria colony and cell colony of plants and animals; |
| 6. | Biotechnology-related products corresponding to those as referred to in subparagraphs 1 through 5. |
| (2) | A person who intends to import any item falling under each subparagraph of paragraph (1) in accordance with the procedures for the shipment prior to the acceptance of an import declaration shall submit documents containing a statement of names and volumes of the relevant items, reasons for the necessity of the shipment prior to the acceptance of an import declaration and other matters to the Minister of Science and ICT. <Amended on Jul. 26, 2017> |
| (3) | Where the Minister of Science and ICT in receipt of the documents under paragraph (2) deems it necessary to ship the relevant items into Korea before an import declaration is accepted after reviewing the details of the documents, he or she shall request the head of a competent customs office to approve the shipment of the relevant items prior to the acceptance of an import declaration pursuant to Article 252 of the Customs Act. In such cases, the head of the competent customs office shall approve the shipment prior to the acceptance of an import declaration in the absence of special circumstances. <Amended on Jul. 26, 2017> |
[This Article Wholly Amended on Mar. 23, 2013]
| Article 24 (Entrustment of Duties) |
| (1) | The Minister of Science and ICT may entrust the duties under his or her jurisdiction, among the following duties, to an institute specializing in biotechnological policies designated under Article 24 (1) of the Act (hereinafter referred to as "policy center"), pursuant to Article 27 (2) of the Act: |
| 4. | Establishment, supplementation, and development of the biotechnology classification system under Article 20 (1) of the Act; |
| (2) | Where the Minister of Science and ICT entrusts duties pursuant to paragraph (1), he or she shall publicly notify the entrusted policy center and the details of the entrusted duties. |
[This Article Newly Inserted on Nov. 20, 2020]
ADDENDUM <Presidential Decree No. 11512, Sep. 22, 1984>
This Decree shall enter into force on the date of its promulgation.
ADDENDA <Presidential Decree No. 13282, Feb. 1, 1991>
Article 1 (Enforcement Date)
This Decree shall enter into force on the date of its promulgation.
Articles 2 through 5 Omitted.
ADDENDA <Presidential Decree No. 13870, Mar. 6, 1993>
Article 1 (Enforcement Date)
This Decree shall enter into force on the date of its promulgation.
Articles 2 through 4 Omitted.
ADDENDA <Presidential Decree No. 14438, Dec. 23, 1994>
Article 1 (Enforcement Date)
This Decree shall enter into force on the date of its promulgation.
Articles 2 through 5 Omitted.
ADDENDA <Presidential Decree No. 14446, Dec. 23, 1994>
Article 1 (Enforcement Date)
This Decree shall enter into force on the date of its promulgation. (Proviso Omitted.)
Articles 2 and 3 Omitted.
ADDENDUM <Presidential Decree No. 14731, Jul. 13, 1995>
This Decree shall enter into force on the date of its promulgation.
ADDENDA <Presidential Decree No. 16326, May 24, 1999>
Article 1 (Enforcement Date)
This Decree shall enter into force on the date of its promulgation.
Articles 2 through 4 Omitted.
ADDENDA <Presidential Decree No. 17048, Dec. 29, 2000>
Article 1 (Enforcement Date)
This Decree shall enter into force on January 1, 2001.
Articles 2 through 8 Omitted.
ADDENDA <Presidential Decree No. 17115, Jan. 29, 2001>
Article 1 (Enforcement Date)
This Decree shall enter into force on the date of its promulgation.
Articles 2 through 5 Omitted.
ADDENDUM <Presidential Decree No. 18452, Jun. 29, 2004>
This Decree shall enter into force on July 1, 2004.
ADDENDA <Presidential Decree No. 20740, Feb. 29, 2008>
Article 1 (Enforcement Date)
This Decree shall enter into force on the date of its promulgation.
Articles 2 through 7 Omitted.
ADDENDA <Presidential Decree No. 22075, Mar. 15, 2010>
Article 1 (Enforcement Date)
This Decree shall enter into force on March 19, 2010. (Proviso Omitted.)
Article 2 Omitted.
ADDENDA <Presidential Decree No. 24423, Mar. 23, 2013>
Article 1 (Enforcement Date)
This Decree shall enter into force on the date of its promulgation. (Proviso Omitted.)
Articles 2 through 7 Omitted.
ADDENDA <Presidential Decree No. 25751, Nov. 19, 2014>
Article 1 (Enforcement Date)
This Decree shall enter into force on the date of its promulgation: Provided, That the amendments to the Presidential Decrees to be amended pursuant to Article 5 of the Addenda, which were promulgated before this Decree enters into force but the enforcement dates of which have yet to arrive, shall enter into force on the enforcement date of the relevant Presidential Decree. Articles 2 through 5 Omitted.
ADDENDA <Presidential Decree No. 28210, Jul. 26, 2017>
Article 1 (Enforcement Date)
This Decree shall enter into force on the date of its promulgation.
Articles 2 through 6 Omitted.
ADDENDA <Presidential Decree No. 31168, Nov. 20, 2020>
Article 1 (Enforcement Date)
This Decree shall enter into force on November 20, 2020.
Article 2 Omitted.
ADDENDUM <Presidential Decree No. 31380, Jan. 5, 2021>
This Decree shall enter into force on the date of its promulgation. (Proviso Omitted.)
ADDENDUM <Presidential Decree No. 32532, Mar. 15, 2022>
This Decree shall enter into force on March 29, 2022.